A pilot study to evaluate the utility of thermography in assessing response to Golimumab treatment in Psoriatic Arthritis (Go-Thermal)
Phase of Trial: Phase II
Latest Information Update: 10 Sep 2016
At a glance
- Drugs Golimumab (Primary)
- Indications Psoriatic arthritis
- Focus Therapeutic Use
- Acronyms Go-Thermal
- Sponsors Merck Sharp & Dohme
- 30 Aug 2016 Status changed from not yet recruiting to recruiting.
- 07 Jul 2016 Planned initiation date changed from 15 Jun 2016 to 20 Sep 2016.
- 19 Jun 2016 Planned initiation date changed from 23 May 2016 to 15 June 2016.